Skip to content
Back to Investors
Angel CoFund

Angel CoFund

Venture Capital

An investment fund backed by the British Business Bank.


Recent investments

Series A
£3.0M

Longwall Ventures and the Angel CoFund led the Series A round to support the development of advanced metal 3D printing systems.

"Additive Manufacturing is currently one of the fastest growing, disruptive technology spaces, providing manufacturers with the ability to produce high value components that would have been impossible even ten years ago. We are excited to be developing our new product in such a high-potential market, and look forward to driving its rapid growth as we prepare to launch in the coming years."
— Will Richardson, Director
Series A
£1.0M

Angel CoFund, Beacon Capital, and Richard Hargreaves led the round, which will fund platform development for legal, RPO, and insurance markets.

"autologyx has maintained an excellent track record since we first invested in the team, and they’ve delivered some first class results for customers. Their growth demonstrates a strong market demand for solutions that can help businesses automate everyday processes and increase efficiency. We are pleased to be part of this round supporting autologyx’s continued success."
— Tim Mills, Investment Director
Series A
£2.0M

The Manchester-based messaging platform raised the capital from backers including GP Bullhound and the Angel CoFund to accelerate expansion.

"Our mission is to make it easier for consumers to connect with service providers in regulated industries like Financial Services. Our clients are using Nivo to deliver simpler mobile experiences, which reduce effort and empower customers. This means everyone saves time, costs go down and satisfaction goes up."
— Mike Common, CEO
Series A
£4.6M

The Belfast-based health technology firm secured Series A backing from investors including Wharton Asset Management and IQ Capital to advance its neurological research and medical trials.

"We are delighted to receive this latest wave of funding, it will enable us to continue to lead the way in developing non-invasive neuro-stimulation technology and will propel our work to a whole new level,"
— Jason McKeown, CEO